On the first quarter, top sales pharmaceutical companies are staring slowly while middle and low companies are making advancements

The top pharmaceutical companies have been begun poorly in performance.

Among the top sale companies, called ‘Big 5,’ 4 of them have showed decreased profitability compared to the same quarter of the last year, except for Yuhan Corporation.

It is tentatively estimated that the average quarterly sales of Big 5, such as Hanmi Pharm, which has newly taken the second, Green Cross, Daewoong Pharma...